Gulu University will receive Shs3.7bn from government to facilitate clinical trials on its developed Covilyce-1 herbal remedy for treatment of Covid-19.
The University’s Public Relations officer, James Onono, told NTV that the approval for the money was given on Wednesday by President Museveni during a meeting with a team of researchers from the institution.
Onono says that the president also tasked the university to follow up on another Shs12bn pledged in 2012 for the construction of faculty of pharmacy.
President Museveni gave the university a go-ahead to continue the development of Covilyce-1, a herbal drug believed to cure Covid-19 in 72 hours.
Museveni told Dr Alice Lamwaka, the lead researcher of the drug, and her team to continue to produce the drug without interference.
However, the president insisted that the drugs be registered and patented in the principal investigator’s name while the university gets a share of it, to protect, encourage and promote the scientists to do greater works.
The observatory tests for the drug will be conducted at Gulu Regional Referral Hospital.
The National Drug Authority (NDA) had ordered the university cease production and marketing of the product until it formalises its production.